Volver a Agenda
Session Chair(s)
Carol Robertson-Plouch
Clinical Research Advisor
Eli Lilly and Company, United States
Learning Objective : Describe the two main types of missing data; Describe the impact that missing data can have on data integrity, statistical analyses, and conclusions from clinical data; Explain scientific and regulatory concerns and historic events; Discuss the positive impact that mitigation can have on missingness, data integrity, and even regulatory approvability.
Speaker(s)
Pharmaceutical Company Sponsor Perspective
Carol Robertson-Plouch
Eli Lilly and Company, United States
Clinical Research Advisor
Two and a Half Missing Data Problems
Lisa LaVange, PHD
University of North Carolina at Chapel Hill, United States
Professor Emerita
A Statistician's Perspective
Joshua Betcher
QuintilesIMS, United States
Sr. Director, Biostatistics
¿Tiene una cuenta?